These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 31808136)
1. Effectiveness and Safety of Restarting Oral Anticoagulation in Patients with Atrial Fibrillation after an Intracranial Hemorrhage: Analysis of Medicare Part D Claims Data from 2010-2016. Newman TV; Chen N; He M; Saba S; Hernandez I Am J Cardiovasc Drugs; 2020 Oct; 20(5):471-479. PubMed ID: 31808136 [TBL] [Abstract][Full Text] [Related]
2. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study. Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992 [TBL] [Abstract][Full Text] [Related]
3. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation. Nielsen PB; Larsen TB; Skjøth F; Lip GY JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151 [TBL] [Abstract][Full Text] [Related]
4. ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NAÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study. Gennaro N; Ferroni E; Zorzi M; Denas G; Pengo V Int J Cardiol; 2024 Jan; 394():131369. PubMed ID: 37722453 [TBL] [Abstract][Full Text] [Related]
5. How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ? Lehtola H; Hartikainen J; Hartikainen P; Kiviniemi T; Nuotio I; Palomäki A; Ylitalo A; Airaksinen KEJ; Mustonen P Clin Cardiol; 2018 May; 41(5):608-614. PubMed ID: 29745996 [TBL] [Abstract][Full Text] [Related]
6. Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage. Wu VC; Huang YC; Chen SW; Liu CH; Chang CW; Chen CC; Chang SH; Lin MS; Lee TH; Chen MC; Hsieh IC; Chu PH; Lin YS Medicine (Baltimore); 2021 Aug; 100(32):e26945. PubMed ID: 34397946 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation Protocol for Secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation. Kimura T; Tucker A; Nakagaki A; Sugimura T; Fukuda S; Katsuno M; Fujita T; Izumi N; Suzuki N; Sako K J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105893. PubMed ID: 34107414 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of Patients With Atrial Fibrillation Newly Recommended for Oral Anticoagulation Under the 2014 American Heart Association/American College of Cardiology/Heart Rhythm Society Guideline. Gray MP; Saba S; Zhang Y; Hernandez I J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301756 [TBL] [Abstract][Full Text] [Related]
9. Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Rivera-Caravaca JM; Esteve-Pastor MA; Camelo-Castillo A; Ramírez-Macías I; Lip GYH; Roldán V; Marín F Expert Opin Pharmacother; 2020 Oct; 21(15):1867-1881. PubMed ID: 32658596 [TBL] [Abstract][Full Text] [Related]
10. Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation. Hernandez I; Zhang Y; Brooks MM; Chin PK; Saba S Stroke; 2017 Jan; 48(1):159-166. PubMed ID: 27909200 [TBL] [Abstract][Full Text] [Related]
11. Ischemic and Bleeding Outcomes in Patients With Atrial Fibrillation and Contraindications to Oral Anticoagulation. Steinberg BA; Ballew NG; Greiner MA; Lippmann SJ; Curtis LH; O'Brien EC; Patel MR; Piccini JP JACC Clin Electrophysiol; 2019 Dec; 5(12):1384-1392. PubMed ID: 31857036 [TBL] [Abstract][Full Text] [Related]
12. Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis. Proietti M; Romiti GF; Romanazzi I; Farcomeni A; Staerk L; Nielsen PB; Lip GYH Int J Cardiol; 2018 Jun; 261():84-91. PubMed ID: 29572080 [TBL] [Abstract][Full Text] [Related]
13. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage. Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848 [TBL] [Abstract][Full Text] [Related]
14. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study. Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack. Coleman CI; Peacock WF; Bunz TJ; Alberts MJ Stroke; 2017 Aug; 48(8):2142-2149. PubMed ID: 28655814 [TBL] [Abstract][Full Text] [Related]
16. Intracranial hemorrhage and subsequent ischemic stroke in patients with atrial fibrillation: a nationwide cohort study. Brønnum Nielsen P; Larsen TB; Gorst-Rasmussen A; Skjøth F; Rasmussen LH; Lip GYH Chest; 2015 Jun; 147(6):1651-1658. PubMed ID: 25412369 [TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulation after catheter ablation of atrial fibrillation and the associated risk of thromboembolic events and intracranial hemorrhage: A systematic review and meta-analysis. Romero J; Cerrud-Rodriguez RC; Diaz JC; Rodriguez D; Arshad S; Alviz I; Cerna L; Rios S; Monhanty S; Natale A; Garcia MJ; Di Biase L J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1250-1257. PubMed ID: 31257677 [TBL] [Abstract][Full Text] [Related]
18. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry. Shiozawa M; Koga M; Inoue H; Yamashita T; Yasaka M; Suzuki S; Akao M; Atarashi H; Ikeda T; Okumura K; Koretsune Y; Shimizu W; Tsutsui H; Hirayama A; Nakahara J; Teramukai S; Kimura T; Morishima Y; Takita A; Yamaguchi T; Toyoda K Int J Stroke; 2023 Oct; 18(8):986-995. PubMed ID: 37154598 [TBL] [Abstract][Full Text] [Related]
19. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial. Nelson SE; Giugliano RP; Antman EM; Park JG; Norden AD; Rost NS; Silverman S; Singhal AB; Lanz HJ; Braunwald E; Ruff CT; J Clin Neurosci; 2021 Apr; 86():294-300. PubMed ID: 33446422 [TBL] [Abstract][Full Text] [Related]
20. Restarting Oral Anticoagulation in Patients With Atrial Fibrillation After an Intracranial Hemorrhage. Nguyen NY; Frishman WH Cardiol Rev; 2020; 28(4):190-196. PubMed ID: 31985523 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]